PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder

Documenti analoghi

• Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
  di: Park, Young-Min, et al.
  Pubblicazione: (2018)
• The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
  di: Lee, Bun-Hee, et al.
  Pubblicazione: (2010)
• Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
  di: Lee, Jeong-Ok, et al.
  Pubblicazione: (2018)
• New Insights Into BDNF Signaling: Relevance to Major Depression and Antidepressant Action
  di: KERMAN, ILAN A.
  Pubblicazione: (2012)
• PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
  di: Myung, Woojae, et al.
  Pubblicazione: (2016)